Henry Schein, Inc. (HSIC)

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Super investor ownership

17 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

• Ken Griffin, CITADEL ADVISORS LLC$243.97M · 0.0% of book
• Burgundy Asset Management, Burgundy Asset Management Ltd.$151.05M · 1.4% of book
• Lyrical Asset Management, LYRICAL ASSET MANAGEMENT LP$122.55M · 1.6% of book
• Richard Pzena, PZENA INVESTMENT MANAGEMENT LLC$71.89M · 0.2% of book
• David Einhorn, DME Capital Management, LP$60.01M · 1.5% of book

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in HSIC

We hold 8 disclosed trades in HSIC by members of Congress and executive-branch officials. The latest 5:

• Michael T. McCaul · HouseSell · $1,001 - $15,000 · traded 18 Jun 2026 · disclosed 8 Jul 2026
• Donald J Trump · Executive branchSell · $15,001 - $50,000 · traded 11 May 2026 · disclosed 1 Jul 2026
• Gilbert Cisneros · HouseSell · $1,001 - $15,000 · traded 31 Mar 2025 · disclosed 7 Apr 2025
• Greg Gianforte · HouseSell · $50,001 - $100,000 · traded 12 Sept 2019 · disclosed 20 Oct 2019
• David B. McKinley · HouseSell · $1,001 - $15,000 · traded 20 Dec 2018 · disclosed 9 Jan 2019

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

Common questions